Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE
NCT ID: NCT04493957
Last Updated: 2023-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2021-09-06
2022-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DRIVing Simulator and People With NeuroCognitive Disorders
NCT06320639
Assessment of the Relevance of a Medico-social Care of Elderly Patients, in Relay Between Hospital and Home: Experimentation of TEMPORARY HERBERGEMENT in Retirement Home " EHPAD " in Seine-et-Marne Department
NCT04014049
Co-LEsions in Alzheimer Disease and Related Disorders
NCT02052947
Predictors Associated With Maintaining Driving in Old Age
NCT05872490
Sharing the Outcome of a Memory Assessment
NCT04935060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
educational intervention
Patients and caregivers included in the "ACCOMPAGNE Education Program" group will benefit from seven group workshops spread over three half-days (once a week over 3 consecutive weeks), animated in pairs, each lasting approximately one and a half hours. and using educational pedagogical methods.
ACCOMPAGNE Education Program
The following workshops will be organised :
* Presentation workshop
* Cognitive skills" workshop
* Perception and Environment workshop
* Responsibilities workshop
* Representation workshop -
* Caregivers workshop,
* Solutions workshop
Control group
Patients and caregivers included in the "Control" group will receive the usual recommendations for driving, issued by their referring doctor in memory consultation during the diagnostic announcement process or during the follow-up of their illness.
Usuals recommandations
Recommendations consist of a description of the cognitive and sensorimotor risk factors specific to the patient for driving and advice for the adaptation of driving or the recommendation of the stopping of driving. It is usually served by oral or written to the patient, with mention in the patient's file of the recommendation and issued in the presence of his close companion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACCOMPAGNE Education Program
The following workshops will be organised :
* Presentation workshop
* Cognitive skills" workshop
* Perception and Environment workshop
* Responsibilities workshop
* Representation workshop -
* Caregivers workshop,
* Solutions workshop
Usuals recommandations
Recommendations consist of a description of the cognitive and sensorimotor risk factors specific to the patient for driving and advice for the adaptation of driving or the recommendation of the stopping of driving. It is usually served by oral or written to the patient, with mention in the patient's file of the recommendation and issued in the presence of his close companion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hold a driving license,
* drive at least twice a week,
* to have given free and informed consent,
* present a diagnosis of major or minor CNS according to DSM V, whose clinically probable or definite etiology is Alzheimer's or related or vascular disease,
* have a result in the Mini Mental State Examination (MMSE) greater than 18,
* have the ability to speak orally enough or write enough to perform clinical evaluations and workshops, be accompanied by a family member present at least 4 hours a week.
Criteria for inclusion of carers:
* to be a caregiver helping the patient for activities of daily living,
* to have given their free and informed consent,
* have the ability to speak orally and write enough to perform clinical assessments.
Exclusion Criteria
* have sensory problems preventing participation in workshops,
* be affected by any debilitating pathology compromising the health of the patient in the short and medium term,
* be unable to express consent. Criteria for non-inclusion of caregivers: have sensory disturbances preventing participation in workshops.
Recruited patients and caregivers should have been informed and signed a consent.
50 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charpennes Hospital
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Delphin-Combe F, Coste MH, Bachelet R, Llorens M, Gentil C, Giroux M, Paire-Ficout L, Ranchet M, Krolak-Salmon P. An innovative therapeutic educational program to support older drivers with cognitive disorders: Description of a randomized controlled trial study protocol. Front Neurol. 2022 Jul 18;13:901100. doi: 10.3389/fneur.2022.901100. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL19_0676
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.